Aum Biosciences is an oncology-focused drug development company in Singapore, researching and developing treatments for prevalent cancers in Asia with expert support.

Rootfacts provides high-throughput screening services for drug development, biotechnology, and advanced research. Their tools enable rapid analysis of large chemical libraries for accuracy and speed.

ArisGlobal's LifeSphere® drug development platform integrates a cognitive computing engine to automate core functions, boosting efficiency, ensuring compliance and lowering costs.

Creative Proteomics is the proteomics division of Creative Dynamics Inc, an integrated CRO company providing a full range of drug development services.

Masuu Global assists with drug development, approval, and dossier lifecycle management, to streamline regulatory submissions.

The global Alzheimers drugs market reached US$ 7.7 billion. IMARC Group expects the market to reach US$ 12.4 billion by 2032, exhibiting a 5.3% growth rate (CAGR) during 2024-2032. The rising prevalence of Alzheimers disease, advancements in drug development, and increasing public and private funding for neurodegenerative disease research are major factors driving market growth.

Acutemarketreports.com provides research on the global theranostics market, which combines drug treatment and diagnostics for enhanced drug development.

The next-generation sequencing market is experiencing growth driven by the increasing importance of companion diagnostics in drug development, the rising incidence of cancer, and the growing adoption of targeted therapies.

We deliver custom solutions for biopharma leaders seeking to improve drug development and facility operations.

Altrid is a global CRO specializing in statistical and clinical programming, CDISC consulting, DMC services, and outsourcing. With extensive staff experience across numerous global studies, they deliver compliance-ready submissions and actionable insights to accelerate drug development in pharma and biotech.